Views: 77
Postmenopausal Women With Breast Cancer Can Have Improved Sex Life With CO2 Laser Therapy
Dedicated Support at Every Step!
Our Doctors are available 24 hours a day, 7 days a week to help you!
A study published in the journal named 'Menopause' has suggested that CO2 laser therapy or treatment can improve and enhance sex life for women in their postmenopause phase.
Most women in their postmenopause complain of painful intercourse, low sex drive, and decreases sexual desire due to a drop in their estrogen levels. This often affects vaginal lubrication and elasticity. The reduced hormone levels often lead to loss of libido postmenopause. Consequently, postmenopausal women often experience vaginal dryness, vaginal atrophy (thinning of the vaginal walls) and inflammation of the vaginal tissues. (Also read: Vaginal dryness at 40! How to get rid of that?)
For women suffering from breast or those who have suffered breast cancer, postmenopausal vaginal symptoms are worse. This usually happens because of the treatment they go through and the side-effects of the medications.

During menopause, women are subject to vaginal changes; the lack of estrogen in the body affects the vaginal elasticity, vaginal moisture, pH levels of the vagina and the integrity of the vaginal tissues. Common vaginal problems that women face after menopause include:
1. Uncomfortable or painful sex - During or after menopause, the vaginal walls get thinner. In most cases, the vaginal folds flatten, preventing expansion of the vagina. As a result, women experience painful sexual intercourse, burning or fiery sensation in the vaginal opening. Apart from intercourse, irritation and vaginal burning sensation can also prevail in general.
2. Burning while urination - The vagina and the urethra both have the same estrogen receptors. The drop in the estrogen levels allows the 'harmful' bacteria to thrive in and around the vaginal walls. The bacterial growth gives a tough time to women while urinating.
3. Urinary leakage - Women often have a hard time reaching the bathroom in their postmenopause. The condition is known as urinary incontinence and happens when the pelvic floor gets weak. Just like the rest of the muscles in your body, the pelvic floor muscles also get weak as women age and approach menopause. Apart from menopause, the weakness of pelvic floor muscles can happen because of chronic constipation, multiple vaginal deliveries, and persistent coughing.
The vaginal problems that women face during postmenopause are collectively known as genitourinary syndrome of menopause (GSM).
Breast cancer survivors are most likely to experience GSM due to endocrine therapy and chemotherapy during their treatment.

However, it has been found out in the study mentioned above that Fractional CO2 therapy is an effective treatment to remodel and regain the vaginal tissues. The study results also indicate that using a Fractional CO2 laser has no side effects and is comparatively safer. The study subjects had experienced reduced vaginal problems and pain and enhanced sexual desire, lubrication, and arousal after CO2 laser therapy.
In recent times, many healthcare organizations, including Pristyn Care, have started leveraging the benefits of CO2 laser therapy for gynaecological treatments. At Pristyn Care, CO2 laser therapy is used for vaginal tightening and vaginal rejuvenation. "Fractional CO2 laser uses heat response to boost blood flow to the vaginal tissues. The process helps in restoring moisture and elasticity of the vaginal walls, vaginal canal, and improves and tone and function of the vaginal muscles. The therapy also treats frequent infection, chronic vaginitis. It induces no side-effects and offers a long-lasting result," says Pristyn Care gynaecologist.
The study stated that the tested breast cancer survivors reported a better sexual function after Fractional CO2 laser therapy.
"This study highlights the issue of sexual dysfunction affecting most survivors of breast cancer and the potential role of CO2 laser therapy in the treatment of GSM and related sexual problems. Additional study is required to better understand the long-term safety and efficacy of this therapy," says Dr. Stephanie Faubion, NAMS medical director and one of the authors of the study.
MBBS, Diploma in Radio Diagnosis & MD-TB & Respiratory Diseases
FREEConsultation Fee
